Glutathione: Real Biochemistry, Contested Supplement

Glutathione is a tripeptide. Three amino acids: glutamate, cysteine and glycine. Every cell makes it. The literature calls it the most abundant antioxidant the body produces itself.¹

Its job is redox regulation. Cells constantly make reactive molecules as a by-product of using oxygen. Glutathione is a main part of how those get neutralised. It is also involved in immune function.¹

That makes glutathione unusual here. Most research peptides are studied for what they might do. Glutathione's role is settled biochemistry. Its open question is a different one.

This is the question that actually matters, and there is a real trial to answer it.

Researchers ran a six-month randomised, double-blinded, placebo-controlled trial in 54 non-smoking adults. Participants took oral glutathione at one of two amounts, or placebo.¹

The team measured glutathione in five places: blood, red cells, plasma, lymphocytes and cheek-lining cells.¹

The result: glutathione levels in blood increased at 1, 3 and 6 months compared with baseline. A set of immune markers was measured in a subset of participants as a secondary outcome.¹

A 2026 review examines the benefits and limitations of oral supplementation more broadly, which is the appropriate next document for anyone weighing the question.³

Across much of the world, glutathione is sold primarily for skin lightening rather than for redox biology. That use has been reviewed, and the review is blunt.

A 2018 paper in *Dermatology Practical and Conceptual* looked at the surrounding hype. It concluded that the widespread use seems unjustified, singling out the parenteral route.²

It gave three reasons. Gaps in what is known about the mechanism. Limited clinical evidence for a skin-lightening role. And statutory bans or advisories issued by certain federal agencies.²

The same review notes that glutathione's approved uses are narrow. They cover severe liver disorders and prevention of certain chemotherapy-associated effects.² Those are not the uses it is marketed for.

Later work has continued in the same direction, with systematic and critical reviews examining the lightening claim across routes of administration.⁴

• Its biology is not in doubt. Glutathione's role as the principal cellular antioxidant is established.¹
• Raising stores is demonstrated; benefit is not. The randomised trial measured levels, not outcomes.¹
• The cosmetic claim is the weakest part of the literature, and regulators have acted on it.²
• "Antioxidant" does not automatically mean good. Redox balance is a balance. More is not simply better, and the trial did not test that premise.

Glutathione is also discussed alongside NAD+, since both sit in cellular metabolism and both attract broad claims. That page is here.